Intuitive Surgical, Inc.

NasdaqGS:ISRG Stock Report

Market Cap: US$178.7b

Intuitive Surgical Future Growth

Future criteria checks 2/6

Intuitive Surgical is forecast to grow earnings and revenue by 12.8% and 11.5% per annum respectively. EPS is expected to grow by 13.3% per annum. Return on equity is forecast to be 15.9% in 3 years.

Key information

12.8%

Earnings growth rate

13.32%

EPS growth rate

Medical Equipment earnings growth16.5%
Revenue growth rate11.5%
Future return on equity15.86%
Analyst coverage

Good

Last updated31 Jan 2026

Recent future growth updates

Recent updates

Intuitive Surgical: Buying The Dip On This Wide-Moat Compounder

Jan 16

The Returns At Intuitive Surgical (NASDAQ:ISRG) Aren't Growing

Sep 09
The Returns At Intuitive Surgical (NASDAQ:ISRG) Aren't Growing

Weekly Picks: 💊 VLS' Solvable Headwinds, VOS' Multi-Year Growth, and ISRG's Valuation Concerns

Jun 17
Weekly Picks: 💊 VLS' Solvable Headwinds, VOS' Multi-Year Growth, and ISRG's Valuation Concerns

Unpleasant Surprises Could Be In Store For Intuitive Surgical, Inc.'s (NASDAQ:ISRG) Shares

Jun 16
Unpleasant Surprises Could Be In Store For Intuitive Surgical, Inc.'s (NASDAQ:ISRG) Shares

It Looks Like Shareholders Would Probably Approve Intuitive Surgical, Inc.'s (NASDAQ:ISRG) CEO Compensation Package

Apr 24
It Looks Like Shareholders Would Probably Approve Intuitive Surgical, Inc.'s (NASDAQ:ISRG) CEO Compensation Package

Intuitive Surgical: Too Many Rain Clouds Coming

Apr 18

Intuitive Surgical: Premium Valuation Meets Mounting Headwinds (Downgrade)

Apr 11
User avatar

From Battle Field to Robotic Surgery

Intuitive Surgical (ISRG) is a pioneer in robotic-assisted surgery, revolutionizing the medical field with its da Vinci surgical system. Founded in 1995, the company has continuously innovated, making

Intuitive Surgical Will Transform Healthcare with 12% Revenue Growth

Increased Adoption of Robotic Surgery:Hospitals and surgical centers continue to adopt Intuitive Surgical’s da Vinci systems as clinical evidence shows improved outcomes and reduced recovery times.Exp

Intuitive Surgical: Getting Closed To Its Fair Value

Mar 09

If EPS Growth Is Important To You, Intuitive Surgical (NASDAQ:ISRG) Presents An Opportunity

Mar 02
If EPS Growth Is Important To You, Intuitive Surgical (NASDAQ:ISRG) Presents An Opportunity

Intuitive Surgical: The Robot Is Well-Oiled

Jan 28

Intuitive Surgical: Second Half 2025 Guidance Is Critical To Maintaining Current Euphoria

Jan 20

Intuitive Surgical: Growing Impressively, But It Appears Overvalued

Dec 27

Intuitive Surgical: One Of The Best Business Models In The World, But Not At This Price

Nov 14

Intuitive Surgical Q3: Da Vinci 5 Robot Set For 2025, But Overvalued

Oct 18

Intuitive Surgical Offers Low Risk, High Return Despite Valuation Concerns

Sep 24

Intuitive Surgical: Detached From Fundamentals

Aug 26
User avatar

Da Vinci 5 Launch And Digital Expansion Set To Revolutionize Surgical Efficiency And Drive Growth

Launch of da Vinci 5 systems and expansion in digital services like My Intuitive app show promise for revenue growth and operational efficiency.

Intuitive Surgical: A Lofty Price To Pay For Innovation, Wait For A Better Entry Point

Aug 20

Intuitive Surgical: Shares Surge, But Now Near Fair Value (Rating Downgrade)

Jul 12

Intuitive Surgical: Sell Signals Abound

May 17

Intuitive Surgical: Growth And Margins Will Be Challenged In 2024

Apr 12

Earnings and Revenue Growth Forecasts

NasdaqGS:ISRG - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202814,8444,3505,102N/A20
12/31/202713,0983,7384,368N/A33
12/31/202611,5353,2404,038N/A33
12/31/202510,0652,856N/AN/AN/A
9/30/20259,6122,7472,2712,961N/A
6/30/20259,1452,6081,9942,826N/A
3/31/20258,7152,4761,7452,731N/A
12/31/20248,3522,3231,3042,415N/A
9/30/20247,8672,2435861,821N/A
6/30/20247,5732,0944201,663N/A
3/31/20247,3191,9885961,708N/A
12/31/20237,1241,7987501,814N/A
9/30/20236,8511,5171,2562,023N/A
6/30/20236,6651,4251,1781,858N/A
3/31/20236,4311,3121,0061,639N/A
12/31/20226,2221,3229581,491N/A
9/30/20226,1181,3781,0911,621N/A
6/30/20225,9641,4351,3101,739N/A
3/31/20225,9061,6441,4601,835N/A
12/31/20215,7101,7051,7502,089N/A
9/30/20215,4891,6891,8852,149N/A
6/30/20215,1631,6231,6621,922N/A
3/31/20214,5511,1731,3151,610N/A
12/31/20204,3581,0611,1431,485N/A
9/30/20204,3071,0539881,410N/A
6/30/20204,3581,1361,0881,532N/A
3/31/20204,6041,3861,2021,618N/A
12/31/20194,4791,3791,1731,598N/A
9/30/20194,2471,314N/A1,384N/A
6/30/20194,0401,210N/A1,307N/A
3/31/20193,8501,147N/A1,223N/A
12/31/20183,7241,128N/A1,170N/A
9/30/20183,570804N/A1,164N/A
6/30/20183,457810N/A1,198N/A
3/31/20183,306778N/A1,183N/A
12/31/20173,138671N/A1,144N/A
9/30/20173,003906N/A1,142N/A
6/30/20172,878819N/A1,057N/A
3/31/20172,790780N/A1,102N/A
12/31/20162,707738N/A1,087N/A
9/30/20162,619722N/A1,041N/A
6/30/20162,522678N/A952N/A
3/31/20162,434628N/A875N/A
12/31/20152,367589N/A806N/A
9/30/20152,285546N/A683N/A
6/30/20152,250502N/A654N/A
3/31/20152,179472N/A623N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ISRG's forecast earnings growth (12.8% per year) is above the savings rate (3.3%).

Earnings vs Market: ISRG's earnings (12.8% per year) are forecast to grow slower than the US market (15.7% per year).

High Growth Earnings: ISRG's earnings are forecast to grow, but not significantly.

Revenue vs Market: ISRG's revenue (11.5% per year) is forecast to grow faster than the US market (10.1% per year).

High Growth Revenue: ISRG's revenue (11.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ISRG's Return on Equity is forecast to be low in 3 years time (15.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/02/02 19:19
End of Day Share Price 2026/01/30 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Intuitive Surgical, Inc. is covered by 55 analysts. 33 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullArgus Research Company
David ToungArgus Research Company
David RescottBaird